Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
Abstract Background Urinary 3-indoxyl sulfate levels as well as fecal short chain fatty acid (SCFA) concentrations are surrogate markers for gut microbiota diversity. Patients with inflammatory bowel diseases (IBDs) and patients with primary sclerosing cholangitis (PSC), a disease closely associated...
Main Authors: | Hauke Christian Tews, Tanja Elger, Stefan Gunawan, Tanja Fererberger, Stefanie Sommersberger, Johanna Loibl, Muriel Huss, Gerhard Liebisch, Martina Müller, Arne Kandulski, Christa Buechler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-023-01929-6 |
Similar Items
-
Urinary chemerin as a potential biomarker for inflammatory bowel disease
by: Stefan Gunawan, et al.
Published: (2022-11-01) -
Altered fecal bile acid composition in active ulcerative colitis
by: Stefanie Sommersberger, et al.
Published: (2023-11-01) -
Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis
by: Julie Hejl, et al.
Published: (2018-03-01) -
Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature
by: Mauro Giuffrè, et al.
Published: (2021-07-01) -
The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study
by: Edyta Szymanska, et al.
Published: (2023-01-01)